Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?

Background Whether sex can influence the clinical response to biological treatment in patients with severe asthma has not been fully addressed. Aims and methods The aim of this study was to investigate in patients with severe asthma undergoing biological treatment the individual evolution of lung fu...

Full description

Bibliographic Details
Main Authors: Roberto Benoni, Silvia Panunzi, Veronica Batani, Francesca Moretti, Stefano Fuggini, Mattia Todesco, Gianenrico Senna, Albino Poli, Andrea Vianello, Marco Caminati
Format: Article
Language:English
Published: European Respiratory Society 2022-07-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/8/3/00670-2021.full
_version_ 1797809430918594560
author Roberto Benoni
Silvia Panunzi
Veronica Batani
Francesca Moretti
Stefano Fuggini
Mattia Todesco
Gianenrico Senna
Albino Poli
Andrea Vianello
Marco Caminati
author_facet Roberto Benoni
Silvia Panunzi
Veronica Batani
Francesca Moretti
Stefano Fuggini
Mattia Todesco
Gianenrico Senna
Albino Poli
Andrea Vianello
Marco Caminati
author_sort Roberto Benoni
collection DOAJ
description Background Whether sex can influence the clinical response to biological treatment in patients with severe asthma has not been fully addressed. Aims and methods The aim of this study was to investigate in patients with severe asthma undergoing biological treatment the individual evolution of lung function measurements and patient-reported asthma control scores over a 12-month follow-up period, in relation to patients’ sex, in different age ranges. Second, the change in the administered dose of oral corticosteroids (OCS) before and after 12 months of treatment was investigated. Results 64 patients (58% female and 42% male) with a median age of 52 years were enrolled in the study. There were no relevant differences between sexes in terms of lung function, patient-reported asthma control, exacerbation rate and daily OCS dose within the study timeframe. A separate sub-analysis by biological treatment confirmed the same finding. Stratifying individuals by age, we showed that older men had lower lung function parameter values (forced expiratory volume in 1 s (FEV1) % predicted and FEV1/forced vital capacity index) than older women, whereas an opposite trend was observed in terms of Asthma Control Test score. No other relevant differences were detected after age stratification. Conclusion According to our findings, sex does not act as a determinant of treatment response to biologicals in people with severe asthma. Although to be confirmed in larger studies, our data suggest that neither sex nor age should limit biological treatment prescription, once the eligibility criteria for that therapy are satisfied.
first_indexed 2024-03-13T06:52:38Z
format Article
id doaj.art-582225a89fa842b78a5bb98c3c7cbf06
institution Directory Open Access Journal
issn 2312-0541
language English
last_indexed 2024-03-13T06:52:38Z
publishDate 2022-07-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj.art-582225a89fa842b78a5bb98c3c7cbf062023-06-07T13:30:19ZengEuropean Respiratory SocietyERJ Open Research2312-05412022-07-018310.1183/23120541.00670-202100670-2021Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?Roberto Benoni0Silvia Panunzi1Veronica Batani2Francesca Moretti3Stefano Fuggini4Mattia Todesco5Gianenrico Senna6Albino Poli7Andrea Vianello8Marco Caminati9 Section of Hygiene, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy Dept of Medicine, University of Verona, Verona, Italy Section of Hygiene, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy Section of Hygiene, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy Dept of Medicine, University of Verona, Verona, Italy Section of Hygiene, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy Respiratory Pathophysiology Unit, Dept of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy Dept of Medicine, University of Verona, Verona, Italy Background Whether sex can influence the clinical response to biological treatment in patients with severe asthma has not been fully addressed. Aims and methods The aim of this study was to investigate in patients with severe asthma undergoing biological treatment the individual evolution of lung function measurements and patient-reported asthma control scores over a 12-month follow-up period, in relation to patients’ sex, in different age ranges. Second, the change in the administered dose of oral corticosteroids (OCS) before and after 12 months of treatment was investigated. Results 64 patients (58% female and 42% male) with a median age of 52 years were enrolled in the study. There were no relevant differences between sexes in terms of lung function, patient-reported asthma control, exacerbation rate and daily OCS dose within the study timeframe. A separate sub-analysis by biological treatment confirmed the same finding. Stratifying individuals by age, we showed that older men had lower lung function parameter values (forced expiratory volume in 1 s (FEV1) % predicted and FEV1/forced vital capacity index) than older women, whereas an opposite trend was observed in terms of Asthma Control Test score. No other relevant differences were detected after age stratification. Conclusion According to our findings, sex does not act as a determinant of treatment response to biologicals in people with severe asthma. Although to be confirmed in larger studies, our data suggest that neither sex nor age should limit biological treatment prescription, once the eligibility criteria for that therapy are satisfied.http://openres.ersjournals.com/content/8/3/00670-2021.full
spellingShingle Roberto Benoni
Silvia Panunzi
Veronica Batani
Francesca Moretti
Stefano Fuggini
Mattia Todesco
Gianenrico Senna
Albino Poli
Andrea Vianello
Marco Caminati
Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
ERJ Open Research
title Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
title_full Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
title_fullStr Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
title_full_unstemmed Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
title_short Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
title_sort clinical response to biologicals for severe asthma any relevance for sex in different age ranges
url http://openres.ersjournals.com/content/8/3/00670-2021.full
work_keys_str_mv AT robertobenoni clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT silviapanunzi clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT veronicabatani clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT francescamoretti clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT stefanofuggini clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT mattiatodesco clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT gianenricosenna clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT albinopoli clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT andreavianello clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges
AT marcocaminati clinicalresponsetobiologicalsforsevereasthmaanyrelevanceforsexindifferentageranges